Treating depression during COVID-19: Considerations for psychological and psychiatric treatment

Presented by Rachel Leonard, PhD, LP, and Christopher Lowden, MD

View slides from this presentation

Review behavioral activation theory and pharmacotherapy for depression, and gain an understanding of the benefits of a combined approach, in part one of this webinar series. Time will also be spent identifying necessary modifications for pharmacotherapy during COVID-19 and adaptations for behavioral activation, which are necessary when treatment is provided via telehealth.

 

Related resources

#
OCD and major depressive disorder (MDD) often co-occur, with individuals…
Learn more
#
To properly address both OCD and PTSD, an evaluation of the traumatic…
Learn more
#
Chronic tic disorders like Tourette Syndrome often present significant…
Learn more

Call 800-767-4411 or go to rogersbh.org to request a free screening.